Soluble tissue factor induces coagulation on tumor endothelial cells in vivo if coadministered with low-dose lipopolysaccharides. [electronic resource]

By:

Philipp, Jana

Contributor(s):

Dienst, Ariane
Unruh, Maike
Wagener, Anke
Grunow, Andrea
Engert, Andreas
Fries, Jochen W U
Gottstein, Claudia

Producer: 20040305Description: 905-10 p. digitalISSN:

1524-4636

Subject(s):

Animals
Blood Coagulation -- drug effects
Dose-Response Relationship, Drug
Drug Synergism
Drug Therapy, Combination
Embolization, Therapeutic -- methods
Enzyme Activation -- drug effects
Factor Xa -- biosynthesis
Humans
Lipopolysaccharides -- administration & dosage
Lymphoma, Non-Hodgkin -- blood
Mice
Mice, Inbred BALB C
Mice, SCID
Peptide Fragments -- administration & dosage
Recombinant Proteins -- administration & dosage
Solubility
Surface Plasmon Resonance
Teratocarcinoma -- blood supply
Thromboplastin -- administration & dosage
Tumor Necrosis Factor-alpha -- analysis
Xenograft Model Antitumor Assays

Online resources:

Available from publisher's website

In: Arteriosclerosis, thrombosis, and vascular biology vol. 23

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

Browse results Close

Back to results

41 [Thrombocytopenia and thrombocytopathy in neonates and infants].
by Brolíková, D
42 [Platelet alpha2-adrenergic receptors in essential hypertension. Number of binding sites, cyclic adenosine monophosphate and platelet aggregation].
by Prikryl, P
43 [Thrombohaemorrhagic syndrome in patients with a myeloproliferative disease with thrombocythemia].
by Penka, M
44 [Significance of urokinase and its inhibitors in the invasiveness and metastasing of malignant tumors].
by Halámková, J
45 Prophylaxis with recombinant factor VIIa for the management of bleeding episodes during immune tolerance treatment in a boy with severe haemophilia A and high-response inhibitors.
by Blatny, J
46 Efficacy and safety of chronic hepatitis C treatment in hemophilic patients.
by Husa, P
47 [Preparation of patients on anticoagulant treatment for invasive surgery].
by Brejcha, M
48 Hemocoagulation disorders in extensively burned patients: pilot study for scoring of the DIC.
by Lipový, B
49 High Level of Circulating Microparticles in Patients with BCR/ABL Negative Myeloproliferative Neoplasm - a Pilot Study.
by Aswad, M H
50 Herpes simplex infection as possible etiology for febrile neutropenia and mucositis in patients treated for hematological malignancies.
by Kubesová, H
51 Sample processing and methodological pitfalls in multiple myeloma research.
by Potácová, A
52 [Warning signs preceding the development of septic shock in patients with neutropenia treated for hematologic malignancies].
by Kubesová, H
53 [Involvement of the cardiac muscle in anemia].
by Elbl, L
54 Effect of rFVIIa dose and time to treatment on patients with haemophilia and inhibitors: analysis of HemoRec registry data from the Czech Republic.
by Salaj, P
55 [The effectiveness of anagrelide treatment in patients with Ph negative myeloproliferative diseases: influence on the incidence of thrombosis in the data from the Registry of patients with essential thrombocythemia and thrombocythemia associated with other myeloproliferative diseases treated with Thromboreductin® to the end of 2012].
by Penka, M
56 Minimal Residual Disease Assessment in Multiple Myeloma by Multiparametric Flow Cytometry.
by Rihova, L
57 [The preparation of a patient with long-term anticoagulant cumarin treatment for invasive surgery].
by Penka, M
58 Severe postpartum haemorrhage treated with recombinant activated factor VII in 80 Czech patients: analysis of the UniSeven registry.
by Blatný, J
59 Biobanking - the First Step to Successful Liquid Biopsy Experiments.
by Almasi, M
60 Isolation and expansion of allogeneic myeloma-specific interferon-gamma producing T cells for adoptive immunotherapy.
by Ocadlikova, Darina

Soluble tissue factor induces coagulation on tumor endothelial cells in vivo if coadministered with low-dose lipopolysaccharides.

APA

Philipp J., Dienst A., Unruh M., Wagener A., Grunow A., Engert A., Fries J. W. U. & Gottstein C. (20040305). Soluble tissue factor induces coagulation on tumor endothelial cells in vivo if coadministered with low-dose lipopolysaccharides. : Arteriosclerosis, thrombosis, and vascular biology.

Chicago

Philipp Jana, Dienst Ariane, Unruh Maike, Wagener Anke, Grunow Andrea, Engert Andreas, Fries Jochen W U and Gottstein Claudia. 20040305. Soluble tissue factor induces coagulation on tumor endothelial cells in vivo if coadministered with low-dose lipopolysaccharides. : Arteriosclerosis, thrombosis, and vascular biology.

Harvard

Philipp J., Dienst A., Unruh M., Wagener A., Grunow A., Engert A., Fries J. W. U. and Gottstein C. (20040305). Soluble tissue factor induces coagulation on tumor endothelial cells in vivo if coadministered with low-dose lipopolysaccharides. : Arteriosclerosis, thrombosis, and vascular biology.

MLA

Philipp Jana, Dienst Ariane, Unruh Maike, Wagener Anke, Grunow Andrea, Engert Andreas, Fries Jochen W U and Gottstein Claudia. Soluble tissue factor induces coagulation on tumor endothelial cells in vivo if coadministered with low-dose lipopolysaccharides. : Arteriosclerosis, thrombosis, and vascular biology. 20040305.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC